Literature DB >> 15685701

Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.

Leida B Rozeman1, Liesbeth Hameetman, Anne-Marie Cleton-Jansen, Anthonie H M Taminiau, Pancras C W Hogendoorn, Judith V M G Bovée.   

Abstract

Enchondromas and conventional central chondrosarcomas are, respectively, benign and malignant hyaline cartilage-forming tumours that originate in the medulla of bone. In order to gain a better understanding of the molecular process underlying malignant transformation of enchondroma, and to investigate whether there is a biological difference between conventional central cartilaginous tumours and those of enchondromatosis or with phalangeal localization, a series of 64 enchondromas (phalanx, n = 21; enchondromatosis, n = 15) and 89 chondrosarcomas (phalanx, n = 17; enchondromatosis, n = 13) was collected. Indian Hedgehog (IHH)/parathyroid hormone related peptide (PTHrP) signalling, an important pathway in chondrocyte proliferation and differentiation within the normal growth plate, was studied by immunohistochemical analysis of the expression of PTHrP, PTHR1, Bcl-2, p21, cyclin D1, and cyclin E. Quantitative real-time PCR for IHH, PTCH, SMO, and GLI2 was performed on a subset of tumours. The data show that IHH signalling is absent in enchondromas and central chondrosarcomas, while PTHrP signalling is active. There was no difference in the expression of any of the molecules between 35 enchondromas and 26 grade I central chondrosarcomas, indicating that PTHrP signalling is not important in malignant transformation of enchondroma. Higher expression of PTHR1 and Bcl-2 was associated with increasing histological grade in chondrosarcoma, suggesting involvement in tumour progression. No difference was found between samples from enchondromatosis patients and solitary cases, suggesting no difference in PTHrP signalling. A small subset of phalangeal chondrosarcomas demonstrated down-regulation of PTHrP, which may be related to its more indolent clinical behaviour. Thus, in both enchondromas and central chondrosarcomas, PTHrP signalling is active and independent of IHH signalling, irrespective of the presence or absence of enchondromatosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685701     DOI: 10.1002/path.1723

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  28 in total

Review 1.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn; Jay S Wunder; Benjamin A Alman
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

2.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

Review 3.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

Review 4.  Molecular pathology of chondroid neoplasms: part 1, benign lesions.

Authors:  W C Bell; M J Klein; M J Pitt; G P Siegal
Journal:  Skeletal Radiol       Date:  2006-09-23       Impact factor: 2.199

5.  CORR Insights®: Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?

Authors:  R Lor Randall
Journal:  Clin Orthop Relat Res       Date:  2016-04-07       Impact factor: 4.176

6.  Loss of β-catenin induces multifocal periosteal chondroma-like masses in mice.

Authors:  Leslie Cantley; Cheri Saunders; Marta Guttenberg; Maria Elena Candela; Yoichi Ohta; Rika Yasuhara; Naoki Kondo; Federica Sgariglia; Shuji Asai; Xianrong Zhang; Ling Qin; Jacqueline T Hecht; Di Chen; Masato Yamamoto; Satoru Toyosawa; John P Dormans; Jeffrey D Esko; Yu Yamaguchi; Masahiro Iwamoto; Maurizio Pacifici; Motomi Enomoto-Iwamoto
Journal:  Am J Pathol       Date:  2012-12-25       Impact factor: 4.307

7.  Differential expression of runx2 and Indian hedgehog in cartilaginous tumors.

Authors:  Hye-Rim Park; Yong-Koo Park
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

8.  Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.

Authors:  Yvonne M Schrage; Liesbeth Hameetman; Karoly Szuhai; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

9.  Patched-one or smoothened gene mutations are infrequent in chondrosarcoma.

Authors:  Taiqiang Yan; Mark Angelini; Benjamin A Alman; Irene L Andrulis; Jay S Wunder
Journal:  Clin Orthop Relat Res       Date:  2008-06-10       Impact factor: 4.176

10.  Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways.

Authors:  A-M Cleton-Jansen; J K Anninga; I H Briaire-de Bruijn; S Romeo; J Oosting; R M Egeler; H Gelderblom; A H M Taminiau; P C W Hogendoorn
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.